Pharmacological modulation of eosinophil influx into the lungs of Brown Norway rats

European Journal of Pharmacology

Volumn 315, Issue 1, 1996, Pages 81-88

  Namovic, Marian T ^a   Walsh, Robin E ^a   Goodfellow, Carole ^a   Harris, Richard R ^a   Carter, George W ^a   Bell, Randy L ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Bronchoalveolar lavage fluid; Inflammation; Leukotriene B4; Leukotriene C4; Leukotriene D4; Leukotriene E4; Pulmonary eosinophilia

Indexed keywords

CALCIMYCIN; DEXAMETHASONE; LEUKOTRIENE; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; MOXILUBANT MALEATE; PEPTIDOLEUKOTRIENE; SALBUTAMOL; THEOPHYLLINE; UNCLASSIFIED DRUG; ZD 204219; ZILEUTON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEVELOPMENT; EOSINOPHILIA; LOEFFLER PNEUMONIA; LUNG LAVAGE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRONCHOALVEOLAR LAVAGE FLUID; CALCIMYCIN; DEXTRANS; EOSINOPHILS; HYDROXYUREA; IONOPHORES; LEUKOTRIENE B4; LEUKOTRIENE C4; LIPOXYGENASE INHIBITORS; MALE; PULMONARY EOSINOPHILIA; RATS; THEOPHYLLINE;

EID: 0030574234     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00590-0     Document Type: Article

References (32)

1. 4 on ionophore A23187 challenge, J. Allergy Clin. Immunol. 74, 310.
2. Calhoun, W.J., J. Sedgewick and W.W. Busse, 1991, The role of eosinophils in the pathophysiology of asthma, Ann. NY Acad. Sci. 629, 62.
3. Carter, G.W., P.R. Young, D.H. Albert, J. Bouska, R. Dyer, R.L. Bell, J.B. Summers and D.W. Brooks, 1991, 5-lipoxygenase inhibitory activity of zileuton, J. Pharmacol. Exp. Ther. 256, 929.
4. 4 antagonists, Curr. Opin. Invest. Drugs 3, 13.
5. Cook, R.M., N.R.J. Musgrove and H. Smith, 1989, Eosinophils and the granulomatous reaction in rats injected with Sephadex particles, Pulm. Pharmacol. 2, 185.
6. Ellwood, W., P.J. Barnes and K. Fan Chung, 1992, Airway hyperresponsiveness is associated with inflammatory cell infiltration in allergic Brown-Norway Rats, Int. Arch. Allergy Immunol. 99, 91.
7. Frigas, E. and G.J. Gleich, 1986, The eosinophil and the pathophysiology of asthma, J. Allergy Clin. Immunol. 77, 527.
8. Harris, R., G.W. Carter, R.L. Bell, J. Moore and D.W. Brooks, 1995, Clinical activity of leukotriene inhibitors, Int. J. Immunopharmacol. 17, 147.
9. 4 and 5-lipoxygenase products, Immunology 51, 679.
10. Henderson, W.R., 1994, The role of leukotrienes in inflammation, Ann. Intern. Med. 121, 684.
11. Horn, R.B., E.D. Robin, J. Theodore and A. Van Kessel, 1975, Total eosinophil counts in the management of bronchial asthma, New Engl. J. Med. 292, 1152.
12. 4 receptor antagonist, Can. J. Physiol. Pharmacol. 73, 191.
13. Jorg, A., W.R. Henderson, R.C. Murphy and S.J. Klebanoff, 1982, Leukotriene generation by eosinophils, J. Exp. Med. 155, 390.
14. Jose, P., D. Griffiths-Johnson, P. Collins, D. Walsh, R. Moqbel, N. Totty, O. Truong and T. Williams, 1994, Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation, J. Exp, Med. 179, 881.
15. Kane, G., M. Pollice, J. Cohn, R. Dworski, J. Murray, J. Sheller, C.J. Kim, J. Fish and S. Peters, 1994, Insights into mechanisms of IgE mediated human lung inflammation derived from segmental antigen challenge studies employing a 5-lipoxygenase inhibitor, Am. Rev. Respir. Dis. 148, A946.
16. Kay, A.B., 1991, Asthma and inflammation, J. Allergy Clin. Immunol. 87, 893.
17. Krell, R.D., D. Aharony, C.K, Buckner, R.D. Keith, E.J. Kusner, D.W. Snyder, P.R. Bernstein, V.G. Matassa, Y.K. Yee, F. Brown, B. Hesp and R.E. Giles, 1990, The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist, Am. Rev. Respir. Dis. 141, 978.
18. 4 and granulocytic infiltration into asthmatic airways, Lancet 341, 989.
19. Laycock, S.M., H. Smith and B.A. Spicer, 1986, Airway hyperreactivity and blood, lung and airway cosinophilia in rats treated with Sephadex particles, Int. Arch. Allergy Appl. Immunol. 81, 363.
20. Lemanske, R.F., Jr. and M.A. Kaliner, 1982, The experimental production of increase eosinophils in rat late-phase reactions. Immunology 45, 561.
21. Muller-Peddinghaus, R., R. Fruchtmann, H.J. Ahr, B. Beckermann, K. Buhner, B. Fugmann, B. Junge, M. Matzke, C. Kohlksdorfer, S. Raddatz, P. Theisen-Popp and H. Mohrs, 1993, BAY X 1005, A new selective inhibitor of LT synthesis: pharmacology and pharmacokinetics, J. Lipid Mediat. 6, 245.
22. Rossi, P., L. Xu, N. Wang and J. Martin, 1993, Allergen-induced airway responses in rats pretreated with Sephadex, Agents Actions 40, 141.
23. Schriber, R.A. and D. Zucker-Franklin, 1974, A method for the induction of blood eosinophilia with simple protein antigens, Cell Immunol. 14, 470.
24. Schriber, R.A. and D. Zucker-Franklin. 1975, Induction of blood eosinophilia by pulmonary embolization of antigen-coated particles: the relationship to cell-mediated immunity. J. Immunol. 114, 1348.
25. 4 toward rabbit neulrophils, J. Immunol. 128, 811.
26. 4 effects on human eosinophil and neutrophil motility in vitro, J. Leukocyte Biol. 55, 183.
27. Spicer, B.A., R.C. Baker, P.A. Halt, S.M. Laycock and H. Smith, 1990, The effects of drugs on Sephadex-induced eosinophilia and lung hyperresponsiveness in the rat, Br. J. Pharmacol. 101, 821.
28. Takatsu, K., S. Takaki and Y. Hitoshi, 1994, Interleukin-5 and its receptor system: implications in the immune system and inflammation, Adv. Immunol. 57, 145.
29. 4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation, J. Immunol. 141, 4291.
30. Walls, R.S. and P.B. Beeson, 1972, Mechanism of eosinophilia. IX: Induction of eosinophilia in rats with certain forms of dextran, Proc. Soc. Exp. Biol. Med. 140, 689.
31. Walsh, R., R. Bell, R. Harris, D. Brooks, and G. Carter, 1994, Characterization of the inhibitory effect of 5-lipoxygenase inhibitors by a single injection of sephadex, FASEB J. 8, A644.
32. Wenzel, S.E., J.B. Trudeau, D.A. Kaminsky, J. Conn, R.J. Martin and J.Y. Westcott, 1995, Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma, Am. J. Respir. Crit. Care Med. 152, 897.